The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.
The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...
The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.
Tuesday's announcement is part of the Trump administration's efforts to reduce prescription drug costs for Americans, with ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Medicare picks Botox and Trulicity for latest round of negotiations The Centers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results